Your session is about to expire
← Back to Search
ICR + Time-Restricted Eating for Coronary Artery Disease (TRE x ICR Trial)
TRE x ICR Trial Summary
This trial will help assess whether reducing the number of hours one eats each day will help reduce levels of LDL cholesterol and improve other markers of metabolic and cardiovascular health.
TRE x ICR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTRE x ICR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TRE x ICR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have heart failure that affects the heart's pumping ability.You have a device supporting the left side of your heart.I am on heart or diabetes medication and cannot change the dose during the study.I am currently in a weight-loss or management program, not including UC San Diego's Cardiac Rehab.Not using the smartphone app to record at least two meals a day for three or more days during the initial period.I have had changes in my thyroid medication doses in the last 3 months.I have a history of adrenal gland problems.I have had surgery to help manage my weight.You currently use a lot of tobacco or illegal drugs, or have been treated for alcohol abuse in the past.I have been using insulin in the past 6 months.You are responsible for taking care of someone who needs help during the night.My heart rhythm is stable, not including controlled atrial fibrillation/flutter.I have a history of cirrhosis.I am enrolled in UC San Diego's 9-week heart rehab program.I have type 1 diabetes and need insulin.You have a history of eating disorders.I have a history of HIV/AIDS.I have a diagnosed inflammatory or rheumatologic condition.I have had a heart transplant in the last year.I am on medication that affects my appetite.You are following a special diet for medical reasons, like Celiac disease.I have advanced chronic kidney disease or am on dialysis.You eat within a time period of less than 14 hours per day, as shown on the mCC app.I have been diagnosed with coronary artery disease.People who work different hours, like at night, are not allowed to participate.I am currently being treated for cancer, except for non-melanoma skin cancer.I am between 18 and 75 years old.
- Group 1: ICR (Intensive Cardiac Rehabilitation)
- Group 2: ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research endeavor need additional participants?
"Affirmative, the listing on clinicaltrials.gov reveals that this medical investigation is actively enrolling participants as of October 3rd 2022. The trial was first published in September 2021 and requires 40 patients from one location."
How many volunteers are participating in the experiment?
"Affirmative, the information found on clinicaltrials.gov confirms that recruitment for this study is currently ongoing. The trial was first listed on September 2nd 2021 and has since been updated as recently as October 3rd 2022. It calls for 40 participants at a single site."
Are geriatric individuals able to partake in the current research?
"The minimum and maximum age for enrollment as per the study's criteria is 18 years old and 75 years old respectively."
Could I potentially meet the requirements to join this experimental program?
"This medical research is enrolling 40 individuals aged 18-75 that are suffering from coronary artery disease. Key criteria for inclusion include not having any alterations to cardiovascular, antihypertensive, or antidiabetic medications and owing a smartphone with either iOS or Android OS. Furthermore, participants must have signed up for the 9 week long Intensive Cardiac Rehabilitation Program at UC San Diego."
Share this study with friends
Copy Link
Messenger